New Study Tracks Real-Life Experience With Trikafta Through Your Smartphone
Last week, we announced the HERO-2: Home Reported Outcomes Study, a first-of-its-kind, at-home observational study that aims to look at the outcomes people experience while using Trikafta®. The study will track the health of individuals with CF and any changes they make to their daily therapies while on Trikafta through self-reported updates on a smartphone app.
Learn more about HERO-2 »
The HERO-2 study is being conducted by Indiana University with funding from the Cystic Fibrosis Foundation. The app powering the study was developed by digital health company Folia Health, and the data will be linked to the CF Foundation’s Patient Registry, a robust database that informs research and care of CF.